Stand out for this role — generate a tailored resume and cover letter in about a minute.
Moderna is seeking a Research Associate in Immuno-Oncology to advance mRNA-based cancer therapies. The role involves bench work to characterize product activity and biomarkers in vitro and in vivo, supporting preclinical and IND-enabling studies within a fast-paced team.
The candidate will perform immune cell isolation, culture, ELISA/MSD, flow cytometry, and PK/PD sample processing, delivering high-quality, reproducible data.
Immuno-Oncology Research at Moderna is seeking a talented and motivated Research Associate to join our efforts in developing new mRNA-based drugs for cancer therapy. The successful candidate will use molecular biology and immunology techniques to characterize Moderna's mRNA products, their activity, and/or relevant biomarkers in vitro and in vivo to support early preclinical research, IND-enabling studies, and/or translational research. This is a bench-focused role requiring technical expertise and the ability to work within a cross-functional, fast-paced team. The successful candidate will execute in vitro and ex vivo experiments as part of a team and consistently deliver high quality, reproducible data.
At Moderna, we believe that when you feel your best, you can do your best work. That's why our benefits and well-being resources are designed to support you, at work, at home, and everywhere in between.
The salary range for this role is $63,200.00 - $100,900.00. This is the lowest to highest salary we in good faith believe we would pay for this role at the time of this posting. An individual's position within the salary range will be based on several factors including, but not limited to, specific competencies, relevant education, qualifications, certifications, experience, skills, performance, and business or organizational needs.
The successful candidate may be eligible for an annual discretionary bonus, other incentive compensation, or equity award, subject to company plan eligibility criteria and individual performance.
Since our founding in 2010, we have aspired to build the leading mRNA technology platform, the infrastructure to reimagine how medicines are created and delivered, and a world-class team. We believe in giving our people a platform to change medicine and an opportunity to change the world.
By living our mission, values, and mindsets every day, our people are the driving force behind our scientific progress and our culture. Together, we are creating a culture of belonging and building an organization that cares deeply for